tykhr
sign in
free sign up
Taro Pharmaceutical Industries Ltd
Drug Manufacturers-Specialty & Generic
Healthcare
TARO
37.58 M shares
NYSE US
traded
02 Jan 2024
listed
no
open
41.45
52 week high
42.31
high
41.85
52 week low
23.30
low
41.26
growth
36.34 %
previous Close
41.78
P/E ratio
market cap
1.42 B
div yield
0
usd
Jun 2023
qoq
revenue
159 M
8.40 %
net incoming
10.03 M
45.13 %
eps
0.00 %
122.22 %
eps surprise
29.03 %
net profit margin
6.31 %
1.00 %
operating incoming
-7.92 M
-185.42 %
net change in cash
-30.33 M
0.00 %
cash on hand
124 M
-19.63 %
cost of revenue
94.81 M
33.76 %
top